NILE THERAPEUTICS, INC. |
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 05-13 | Transcript : Capricor Therapeutics, Inc., Q1 2024 Earnings Call, May 13, 2024 | |
| 05-13 | Earnings Flash (CAPR) CAPRICOR THERAPEUTICS Posts Q1 Revenue $4.9M, vs. Street Est of $9.7M | MT |
Chart calendar Nile Therapeutics, Inc.
89b142fbe41b.CzWL4HDJUQh-6J4V6H9NhMNGdEoEvrw581S-AGbKXlU.O3D51BazIXgJsO5shSx98bAvRjBCk-9VqzrbNTP_DgRHb_ywJosQWhjY7Q~28df8bd43e9f2b97ae7ef7226c965139
Upcoming events on Nile Therapeutics, Inc.
Past events on Nile Therapeutics, Inc.
| 14/05/2024 18:00 | Annual General Meeting |
| 13/05/2024 21:30 | Q1 2024 Earnings Call |
| 13/05/2024 21:05 | Q1 2024 Earnings Release |
| 08/05/2024 | Society of Extracellular Vesicles International Meeting |
| 06/05/2024 | American Society of Gene & Cell Therapy Meeting |
| 29/04/2024 13:30 | CAP-1002 DMD Update Call |
| 03/04/2024 18:30 | Cantor Fitzgerald Muscular Dystrophy Symposium |
| 26/03/2024 18:00 | H.C. Wainwright Cell Therapy Virtual Conference |
| 06/03/2024 16:45 | MDA Clinical and Scientific Conference |
| 29/02/2024 21:30 | Q4 2023 Earnings Call |
| 29/02/2024 21:05 | Q4 2023 Earnings Release |
| 14/11/2023 21:30 | Q3 2023 Earnings Call |
| 14/11/2023 21:05 | Q3 2023 Earnings Release |
| 25/10/2023 18:00 | Business Update Call |
| 10/10/2023 | Cell & Gene Meeting on the Mesa Conference |
| 06/10/2023 20:30 | World Muscle Society International Congress |
| 29/09/2023 13:30 | Business Update Call |
| 07/08/2023 21:30 | Q2 2023 Earnings Call |
| 07/08/2023 21:05 | Q2 2023 Earnings Release |
| 30/06/2023 16:45 | Parent Project Muscular Dystrophy Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,01 0,84 19.43% | 0,31 0,25 23.12% | 0,24 0,22 10.07% | 2,55 1,60 59.87% | 25,2 21,0 19.64% | 22,1 |
|
EBITDA Million USD | Released Forecast Spread | -7,73 -8,40 7.93% | 0,00 0,00 - | -20,9 -19,4 -7.93% | -29,2 -30,1 3.11% | -22,8 -30,4 25.03% | -42,8 |
|
EBIT Million USD | Released Forecast Spread | -7,73 -8,26 6.39% | -13,7 -13,5 -1.26% | -20,9 -19,2 -9.1% | -29,7 -30,2 1.56% | -23,9 -28,1 15.08% | -39,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -7,64 -8,17 6.5% | -13,7 -13,5 -1.25% | -20,0 -18,3 -9.24% | -29,0 -29,8 2.49% | -22,3 -26,6 16.21% | -38,3 |
|
Net income Million USD | Released Forecast Spread | -7,64 -8,17 6.5% | -13,7 -13,5 -1.25% | -20,0 -18,3 -9.24% | -29,0 -29,8 2.49% | -22,3 -26,6 16.2% | -38,3 |
|
EPS USD | Released Forecast Spread | -2,06 -1,97 -4.83% | -0,88 -0,88 0% | -0,87 -0,80 -8.75% | -1,18 -1,22 3.01% | -0,83 -1,04 20.19% | -1,17 |
| Announcement Date | 18/03/20 | 11/03/21 | 10/03/22 | 15/03/23 | 29/02/24 | - |
Quarterly results
| Fiscal Period | December | 2020 S1 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,24 0,43 -45.22% | 0,00 0,00 - | 0,00 0,20 - | 1,59 0,14 1036.84% | 0,96 0,01 19098% | 2,99 0,50 497.34% | 3,92 1,60 144.84% | 6,19 3,17 95.44% | 12,1 7,95 52.05% | 4,91 9,70 -49.41% | 4,41 | 4,30 | 8,49 | 0,00 | |
|
EBITDA Million USD | Released Forecast Spread | -6,38 -4,80 -32.91% | -7,32 -6,00 -22.03% | -6,48 -7,00 7.46% | -7,87 -8,50 7.36% | -7,95 -8,00 0.57% | -7,49 -8,60 12.88% | -0,76 -7,60 90.06% | -3,60 | -11,4 | -11,7 | -9,50 | ||||
|
EBIT Million USD | Released Forecast Spread | -6,38 -4,43 -44.14% | -7,32 -7,07 -3.55% | -6,48 -7,85 17.49% | -8,07 -8,57 5.9% | -8,18 -9,27 11.7% | -7,75 -8,98 13.71% | -6,86 -9,33 26.41% | -1,06 4,31 -124.68% | -10,3 -3,81 -169.66% | -10,7 | -11,0 | -6,08 | -12,1 | ||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -6,19 -4,46 -38.71% | -7,11 -7,07 -0.54% | -6,37 -7,47 14.67% | -7,72 -8,49 9.06% | -7,77 -8,39 7.46% | -7,37 -8,73 15.62% | -6,39 -9,15 30.12% | -0,76 -5,06 84.94% | -9,79 -3,48 -181.28% | -10,5 | -11,0 | -6,95 | -12,1 | ||
|
Net income Million USD | Released Forecast Spread | -6,19 -4,46 -38.71% | -7,11 -7,07 -0.54% | -6,37 -7,47 14.67% | -7,72 -8,49 9.06% | -7,77 -8,39 7.46% | -7,37 -8,73 15.62% | -6,39 -9,15 30.12% | -0,76 -5,06 84.94% | -9,79 -3,48 -181.28% | -10,5 | -11,0 | -6,95 | -12,1 | ||
|
EPS USD | Released Forecast Spread | -0,26 -0,19 -36.84% | -0,32 | -0,29 -0,26 -13.73% | -0,26 -0,31 15.22% | -0,31 -0,34 8.82% | -0,31 -0,32 3.13% | -0,29 -0,35 16.35% | -0,25 -0,30 17.58% | -0,02 -0,20 89.74% | -0,31 -0,11 -173.54% | -0,33 | -0,34 | -0,20 | -0,31 | |
| Announcement Date | 06/08/20 | 10/03/22 | 10/05/22 | 10/08/22 | 10/11/22 | 15/03/23 | 11/05/23 | 07/08/23 | 14/11/23 | 29/02/24 | 13/05/24 | - | - | - | - |
More events
Past sector events for Nile Therapeutics, Inc.
- Stock Market
- Equities
- CAPR Stock
- Stock
- Calendar Nile Therapeutics, Inc.
